
Have any connection and interest in understanding not only pancreatic cancer, but to cancer in general? Listen to a surgeon scientist and a Ph.D. scientist, both in the middle of their careers and leaders at their respective institutions, who have combined 50+ years of experience in the field--discuss with thought leaders in oncology the politics, the landscape, the science, the clinical trials, t... more
| Publishes | Twice monthly | Episodes | 12 | Founded | 6 years ago |
|---|---|---|---|---|---|
| Categories | MedicineHealth & Fitness | ||||

To highlight the beginning of pancreatic cancer awareness month, we have saved the best - an inspiring discussion with Dr. Charles J. Yeo who is a master surgeon, clinician-scientist, mentor, and an inspiration to us all in the community from patient... more
Join us for a lively conversation with Bruce Platt (a Philly and Purple warrior legend), who is working hard in the trenches to improve the lives of people and families affected by this disease.
Chris Joseph as a survivor, living with pancreatic cancer, talks about his journey- the good, the tough and the spiritual bumps on his road to a healthy lifestyle and approach to tackling this disease. He has inspiring words for all!
You don't want to miss this conversation with the ultimate Purple Warriors, Dr. Lynn Matrisian(CSO) and President and CEO Julie Fleshman of the Pancreatic Cancer Action Network, and discussed everything from our collective concerns about clinical tri... more
After taking a brief break, Winter and Brody return with a stimulating discussion with Dr. Peter Allen (Duke University). Topics include where have we come with patient outcomes over the past few decades; training surgeons; and can we identify high ... more
We have a stimulating conversation about evolution, science, innovation and pancreatic cancer with a true maverick in the field, Dr. Christine Iacobuzio-Donahue.
The guys talk about the state of the union of early detection strategies and some new opportunities from weight loss to depression.
Drs. Winter and Brody discuss the state of the union of precision medicine with a leader in the field (Dr. Mike Pishvaian).
Disclosures: Brody is on the SAB (Perthera) and Pishvaian was the CMO (no longer paid) of Perthera, and advised for Astraz... more
My family member was recently diagnosed with pancreatic cancer, and I’ve become a research robot ever since. I’m making my way through every episode of this podcast and appreciate it so much! Learning a ton about different aspects of this disease.
Full disclosure, I met Dr Winter New Years Eve 2015 when he came to my hospital room to explain what had been found in my biopsy that he had “peeked in on as it was being performed”. I’ve been a fan ever since!
These podcasts bring to light the difficulties to get to the casual state(s) of the disease. But with such smart people working on this, there is such great hope for the future. I especially enjoy the pragmatism (weight loss, diabetes, etc) vs the in depth scientific knowledge di... more
It is both rare and refreshing to listen to a clinical/scientist and researcher share their innermost fears, concerns, experiences, goals and wishlist for finding more effective treatments and more focused experiments to render better results for this insidious disease.
How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.
Apple Podcasts | #126 |










Listeners, social reach, demographics and more for this podcast.
| Gender Skew | Location | Interests | |||
|---|---|---|---|---|---|
| Professions | Age Range | Household Income | |||
| Social Media Reach | |||||
Rephonic provides a wide range of podcast stats for The Pancreatic Cancer Podcast. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to The Pancreatic Cancer Podcast and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.
Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for The Pancreatic Cancer Podcast, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.
Rephonic provides comprehensive predictive audience data for The Pancreatic Cancer Podcast, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.
To see how many followers or subscribers The Pancreatic Cancer Podcast has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.
The Pancreatic Cancer Podcast launched 6 years ago and published 12 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.
Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.
Rephonic pulls ratings and reviews for The Pancreatic Cancer Podcast from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.
View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.
Rephonic provides full transcripts for episodes of The Pancreatic Cancer Podcast. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.